We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CIT:GETTEXCintas Corporation Analysis

Data as of 2026-03-15 - not real-time

$105.69

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical snapshot: Citigroup’s stock is trading at $105.69, which lies below the 20‑day SMA of $110.92 and the 50‑day SMA of $114.79, yet remains above the 200‑day SMA of $100.75, indicating a short‑term pullback within a longer‑term uptrend. The RSI of 38.9 hints at a modest oversold condition, while the MACD line sits beneath its signal, flagging bearish momentum. Current price is perched near the identified support at $102.01 with resistance around $117.04, and the stock is experiencing elevated 30‑day volatility of 41% and a beta of 1.27, underscoring heightened market sensitivity.
Fundamental outlook: Valuation appears attractive, with a trailing P/E of 15.1 versus the industry average of 16.35 and a forward P/E of 8.7, suggesting significant upside potential. The dividend yield of 2.27% and a modest payout ratio of 33% support a sustainable income stream, bolstered by a massive cash pile of $989 B against $777 B of debt. Although operating cash flow is negative, analysts collectively rate the stock as a Buy with a median target of $134.5, implying a 27% upside, and the prevailing market sentiment leans toward “Greed.”

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price testing near $102 support
  • bearish MACD alignment
  • RSI approaching oversold territory

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation gap vs industry peers
  • robust dividend yield and payout ratio
  • analyst consensus buy with strong upside target

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • sustained upside potential to $134 median target
  • global diversification across major markets
  • stable dividend income supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth4.40%
Profit Margin18.89%
P/E Ratio15.1
ROE6.83%
ROA0.58%
P/B Ratio1.0
Op. Cash Flow$-67632001024
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI38.9
Support$102.01
Resistance$117.04
MA 20$110.92
MA 50$114.79
MA 200$100.75
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Target Price$134.32
Upside/Downside27.09%
GradeUndervalued
TypeBlend
Dividend Yield2.27%

Risk Assessment

Beta1.27
Volatility41.25%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.